Biol Reprod Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


BOR - Papers in Press, published online ahead of print July 14, 2004.
Biol Reprod 2004, 10.1095/biolreprod.104.031161
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
71/5/1605    most recent
biolreprod.104.031161v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lei, Z.M.
Right arrow Articles by Rao, Ch.V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lei, Z.M.
Right arrow Articles by Rao, Ch.V.
Agricola
Right arrow Articles by Lei, Z.M.
Right arrow Articles by Rao, Ch.V.
BIOLOGY OF REPRODUCTION 71, 1605–1613 (2004)
DOI: 10.1095/biolreprod.104.031161
© 2004 by the Society for the Study of Reproduction, Inc.


Testis

Testicular Phenotype in Luteinizing Hormone Receptor Knockout Animals and the Effect of Testosterone Replacement Therapy1

Z.M. Lei2,3, S. Mishra4, P. Ponnuru4, X. Li4, Z.W. Yang5, and Ch.V. Rao3,4

Division of Research,4 Department of Obstetrics, Gynecology, and Women's Health, University of Louisville Health Sciences Center, Louisville, Kentucky 40292 Morphometric Research Laboratory,5 North Sichuan Medical College, Sichuan, China

The LH receptor knockout model, developed in our laboratory, was used in determining what FSH alone can do in the absence of LH signaling and whether any of the testicular LH actions are not mediated by androgens. The results revealed that null animals contained smaller seminiferous tubules, which contained the same number of Sertoli cells, spermatogonia, and early spermatocytes as wild-type siblings. The number of late spermatocytes, on the other hand, was moderately decreased, the number of round spermatids was dramatically decreased, and elongated spermatids were completely absent. These changes appear to be due to an increase in apoptosis in spermatocytes. While the number of Leydig cells progressively increased from birth to 60 days of age in wild-type animals, they remained unchanged in null animals. Consequently, 60-day-old null animals contained only a few Leydig cells of fetal type. The age-dependent increase in testicular macrophages lagged behind in null animals compared with wild-type siblings. Orchidopexy indicated that –/– testicular phenotype was not due to abdominal location. Rather, it was mostly due to androgen deficiency, as 21-day testosterone replacement therapy stimulated the growth of seminiferous tubules, decreased apoptosis, and increased the number of late spermatocytes and round spermatids and their subsequent differentiation into mature sperm. The therapy, however, failed to restore adult-type Leydig cells and testicular macrophage numbers to the wild-type levels. In summary, our data support the concept that FSH signaling alone can maintain the proliferation and development of Sertoli cells, spermatogonia, and early spermatocytes. LH actions mediated by testosterone are required for completion of spermatogenesis, and finally, androgen-independent actions of LH are required for the formation of adult-type Leydig cells and recruitment of macrophages into the testes.

1 Supported by NIH grant HD-40223.

2 Correspondence: Z.M. Lei, Department of Obstetrics, Gynecology, and Women's Health, 438 MDR Building, University of Louisville Health Sciences Center, Louisville, KY 40292. FAX: 502 852 0881; zhenmin.lei{at}louisville.edu

3 Correspondence: Ch. V. Rao, Department of Obstetrics, Gynecology, and Women's Health, 438 MDR Building, University of Louisville Health Sciences Center, Louisville, KY 40292. FAX: 502 852 0881; cvrao001{at}louisville.edu




This article has been cited by other articles:


Home page
EndocrinologyHome page
W. V. Ingman and S. A. Robertson
Transforming Growth Factor-{beta}1 Null Mutation Causes Infertility in Male Mice Associated with Testosterone Deficiency and Sexual Dysfunction
Endocrinology, August 1, 2007; 148(8): 4032 - 4043.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
F.P. Yuan, D.X. Lin, C.V. Rao, and Z.M. Lei
Cryptorchidism in LhrKO animals and the effect of testosterone-replacement therapy
Hum. Reprod., April 1, 2006; 21(4): 936 - 942.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Society for the Study of Reproduction.